Aurobindo Pharma divests stake in Australian subsidiary to Eris Pharma

In a move to focus the growth markets, the Hyderabad-based Aurobindo Pharma has sold off its step-down subsidiary in Australia, Aurobindo Pharma (Australia) Pty Ltd, to Eris Pharma Australia Pty Ltd. The company informed BSE on April 10, 2015 that Aurobindo Pharma Limited has divested its step-down subsidiary, Aurobindo Pharma (Australia) Pty Ltd to Eris Pharma Australia Pty Ltd.
 
Aurobindo Pharma will, however, under an agreement continue to manufacture and supply the products to Eris Pharma for Australian and New Zealand market over next few years. This divestment is in line with Aurobindo Pharma’s strategy to focus on US, EU and key emerging markets. This subsidiary was not contributing any profit to Aurobindo, added the company in the BSE filing.